Years of Life Lost Due to Bladder Cancer Among the Inhabitants of Poland in the Years 2000 to 2014

Overview

Journal Cent European J Urol

Specialty Urology

Date 2018 Feb 8

PMID 29410882

Citations 3

Authors

Mateusz Jobczyk

Malgorzata Pikala

Waldemar Rozanski

Irena Maniecka-Bryla

Affiliations

Soon will be listed here.

Abstract

Introduction: The aim of the study is to evaluate the number of years of life lost in inhabitants of Poland due to bladder cancer (BC), identify trends of the mortality and calculate the pace of change which has happened over the period of the first fifteen years of the 21 century.

Material And Methods: The study material was a database including 44,283 death certificates of Polish inhabitants who died due to bladder cancer in the period 2000-2014. The number of years of life lost were calculated using the SEYLL indices: SEYLLp (Standard Expected Years of Life Lost per living person) and SEYLLd (Standard Expected Years of Life Lost per death).

Results: The crude death rates (CDR) index increased from 10.79 per 100,000 males in 2000 to 14.30 in 2014 (Annual Percentage Change [APC] = 2.1%, p <0.05). In women, the group value of the CDR index increased from 2.50 in 2000 to 3.83 in 2014 (APC = 2.9%, p <0.05). The standardized death rates (SDR) index fell from 23.27 in 2000 to 22.48 in 2014 (APC = -0.1%, p >0.05) in men, but rose from 3.54 in 2000 to 3.83 in 2014 (APC = 0.4%, p <0.05) in women.The SEYLLp index (per 100,000 population) due to bladder cancer in Poland increased from 202.9 in 2000 to 243.4 in 2014 (APC = 1.3%, p <0.05) in men, and from 40.4 in 2000 to 60.1 in 2014 (APC = 2.7%, p <0.05) in women.

Conclusions: Despite the prolongation of patient life, as shown by the SEYLLd factor, Polish patients still lose too many years of life due to BC than compared to United States patients.

Citing Articles

Urogenital Cancer Epidemiology in Poland (1980-2020): A Narrative Review.

Wnetrzak I, Didkowska J, Sosnowski R, Czajkowski M, Sigorski D, Malkiewicz B Cancers (Basel). 2025; 17(2).

PMID: 39858098 PMC: 11763937. DOI: 10.3390/cancers17020316.

Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer.

Bilski K, Zeber-Lubecka N, Kulecka M, Dabrowska M, Balabas A, Ostrowski J Curr Issues Mol Biol. 2024; 46(4):3595-3609.

PMID: 38666955 PMC: 11048804. DOI: 10.3390/cimb46040225.

Diminishing the Gender-Related Disparity in Survival among Chemotherapy Pre-Treated Patients after Radical Cystectomy-A Multicenter Observational Study.

Kaczmarek K, Leminski A, Malkiewicz B, Gurwin A, Lisinski J, Slojewski M J Clin Med. 2023; 12(4).

PMID: 36835795 PMC: 9958943. DOI: 10.3390/jcm12041260.

Mortality Trends Due to Skin Melanoma in Poland in the Years 2000-2020.

Dziankowska-Zaborszczyk E, Maniecka-Bryla I, Pikala M Int J Environ Res Public Health. 2022; 19(23).

PMID: 36498192 PMC: 9739595. DOI: 10.3390/ijerph192316118.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Burger M, Catto J, Dalbagni G, Grossman H, Herr H, Karakiewicz P . Epidemiology and risk factors of urothelial bladder cancer. Eur Urol. 2012; 63(2):234-41. DOI: 10.1016/j.eururo.2012.07.033. View

Chavan S, Bray F, Lortet-Tieulent J, Goodman M, Jemal A . International variations in bladder cancer incidence and mortality. Eur Urol. 2014; 66(1):59-73. DOI: 10.1016/j.eururo.2013.10.001. View

Rachtan J . Smoking, passive smoking and lung cancer cell types among women in Poland. Lung Cancer. 2002; 35(2):129-36. DOI: 10.1016/s0169-5002(01)00330-0. View

Jassem J, Przewozniak K, Zatonski W . Tobacco control in Poland-successes and challenges. Transl Lung Cancer Res. 2015; 3(5):280-5. PMC: 4367772. DOI: 10.3978/j.issn.2218-6751.2014.09.12. View

Li C, Ekwueme D, Rim S, Tangka F . Years of potential life lost and productivity losses from male urogenital cancer deaths--United States, 2004. Urology. 2010; 76(3):528-35. DOI: 10.1016/j.urology.2010.04.030. View

Stenzl A, Cowan N, De Santis M, Kuczyk M, Merseburger A, Ribal M . Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol. 2011; 59(6):1009-18. DOI: 10.1016/j.eururo.2011.03.023. View

Levi F, Lucchini F, Negri E, Boyle P, La Vecchia C . Cancer mortality in Europe, 1995-1999, and an overview of trends since 1960. Int J Cancer. 2004; 110(2):155-69. DOI: 10.1002/ijc.20097. View

Bryla M, Dziankowska-Zaborszczyk E, Maniecka-Bryla I . Standard expected years of life lost due to tuberculosis in Poland. Int J Tuberc Lung Dis. 2017; 21(2):202-207. DOI: 10.5588/ijtld.16.0268. View

10.

Pipe A, Papadakis S, Reid R . The role of smoking cessation in the prevention of coronary artery disease. Curr Atheroscler Rep. 2010; 12(2):145-50. DOI: 10.1007/s11883-010-0105-8. View

11.

Poletajew S, Braticevici B, Brisuda A, Cauni V, Grygorenko V, Lesnyak M . Timing of radical cystectomy in Central Europe - multicenter study on factors influencing the time from diagnosis to radical treatment of bladder cancer patients. Cent European J Urol. 2015; 68(1):9-14. PMC: 4408384. DOI: 10.5173/ceju.2015.01.444. View

12.

Pikala M, Bryla M, Bryla P, Maniecka-Bryla I . Years of life lost due to external causes of death in the lodz province, poland. PLoS One. 2014; 9(5):e96830. PMC: 4014557. DOI: 10.1371/journal.pone.0096830. View

13.

Zatonski W, Przewozniak K, Sulkowska U, West R, Wojtyla A . Tobacco smoking in countries of the European Union. Ann Agric Environ Med. 2012; 19(2):181-92. View

14.

Babjuk M, Oosterlinck W, Sylvester R, Kaasinen E, Bohle A, Palou-Redorta J . EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol. 2011; 59(6):997-1008. DOI: 10.1016/j.eururo.2011.03.017. View

15.

Pikala M, Maniecka-Bryla I . Years of life lost due to malignant neoplasms characterized by the highest mortality rate. Arch Med Sci. 2014; 10(5):999-1006. PMC: 4223125. DOI: 10.5114/aoms.2013.36237. View

16.

Maniecka-Bryla I, Bryla M, Bryla P, Pikala M . The burden of premature mortality in Poland analysed with the use of standard expected years of life lost. BMC Public Health. 2015; 15:101. PMC: 4328237. DOI: 10.1186/s12889-015-1487-x. View

17.

Scosyrev E, Golijanin D, Wu G, Messing E . The burden of bladder cancer in men and women: analysis of the years of life lost. BJU Int. 2011; 109(1):57-62. DOI: 10.1111/j.1464-410X.2011.10318.x. View

18.

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

19.

Poletajew S, Biernacki R, Buraczynski P, Chojnacki J, Czarniecki S, Gajewska D . Stage of bladder cancer in Central Europe - Polish perspective. Neoplasma. 2016; 63(4):642-7. DOI: 10.4149/neo_2016_420. View

20.

Plass D, Chau P, Thach T, Jahn H, Lai P, Wong C . Quantifying the burden of disease due to premature mortality in Hong Kong using standard expected years of life lost. BMC Public Health. 2013; 13:863. PMC: 3848717. DOI: 10.1186/1471-2458-13-863. View